Meet the Experts: Update on Lung Cancer

 

Meet the Experts: Update on Lung Cancer
Avatar

Update on Anti-EGFR Treatment in mNSCLC: EGFR Mutation Subtypes, Outcomes of Single-Agent vs. Combination Options, 1L Therapy Perspectives

By Meet the Experts: Update on Lung Cancer FEATURING Pasi Janne
By Meet the Experts: Update on Lung Cancer FEATURING Pasi Janne
48 views
June 4, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das
Videos
10:05

Update on Anti-EGFR Treatment in mNSCLC: EGFR Mutation Subtypes, Out…

Meet the Experts: Update on Lung Cancer

P. Janne

48 views
07:07

Treatment Approach for EGFR-Mutant mNSCLC: Navigating Efficacy Data

Meet the Experts: Update on Lung Cancer

P. Janne

196 views
14:29

Approaches to Treating Drug Resistance in EGFRm NSCLC: What Options …

Meet the Experts: Update on Lung Cancer

P. Janne

35 views
07:18

IO for Locally Advanced NSCLC: Overview of Standard Options and Pers…

Meet the Experts: Update on Lung Cancer

F. Cappuzzo

91 views
16:53

IO in mNSCLC: Chemoimmunotherapy in (Non-)squamous Disease, Low Chem…

Meet the Experts: Update on Lung Cancer

F. Cappuzzo

139 views
08:05

Overview of Treatment Options for SCLC: SoC Chemotherapy & Novel Tar…

Meet the Experts: Update on Lung Cancer

T. Mok

136 views
16:05

Overview of Immunotherapy Options in SCLC: Efficacy Data for Single …

Meet the Experts: Update on Lung Cancer

T. Mok

286 views